# C-SDLC v2 Sprint Review Quality Evaluation

## Blocking Issues

### Q1: P1-15 depends on machine-local evidence that the packet does not retain

- Severity: blocker.
- Affected quality dimensions: evidence quality, unsupported claims, publication
  safety, and reproducibility.
- Evidence: `SPRINT_REVIEW.md:232-248`, `ISSUE_COVERAGE.md:43-49`,
  `GAP_ANALYSIS.md:23`, and
  `specialists/DOCS_LIFECYCLE_REVIEW.md:31-55` make the 108 ignored card files,
  their field values, and their absence from the review worktree central to
  P1-15. The docs specialist explicitly says those files are ignored,
  untracked, machine-local, absent from this worktree, and mutable. The packet
  contains no sanitized observation manifest, hashes, captured field excerpts,
  or command output from which a publication reader can verify the claimed
  108/108 inventory or the stated contradictions.
- Required correction before publication: retain a sanitized evidence manifest
  that identifies every observed card by repo-relative logical path, issue,
  card type, collection time, content hash, tracking/ignore status, and only the
  fields needed to prove each contradiction. Include the collection commands
  and their results, or an equivalently reviewable machine-readable capture.
  If that evidence cannot be retained, narrow P1-15 and every dependent summary
  claim to the tracked evidence that can be reproduced, and label all local-card
  observations as non-portable context rather than publication-grade evidence.

### Q2: Complete scope and lane coverage are asserted without a retained scope manifest

- Severity: blocker.
- Affected quality dimensions: scope completeness, lane coverage, evidence
  quality, and unsupported claims.
- Evidence: `DESIGN.md:19-28` says a bounded repository packet and complete
  evidence graph were built. `SPRINT_REVIEW.md:454-482` says all required lanes
  and broad source surfaces were covered, while specialist artifacts make
  similar claims about every module, binary, test, card, gate record, and PR.
  The packet does not contain a repository-packet manifest, changed-path list,
  source inventory, evidence index, or skipped-surface list. It therefore does
  not let a reader reconcile the 18 issue/15 PR delivery graph to the files and
  artifacts actually reviewed.
- Required correction before publication: add a retained scope/evidence index
  for reviewed revision `7c3e1e0e86a4ca982231ce91c39073530c5408e6` that lists
  the scope type, controlling umbrella or an explicit no-single-umbrella
  rationale, all child issues, all PRs, changed paths or reviewed source
  inventory, lifecycle and closeout artifacts, and every skipped or unavailable
  surface with a reason. Reconcile each specialist's coverage claim to that
  index. Until then, replace absolute claims such as "complete", "all", and
  "every" with the bounded surfaces directly evidenced by the packet.

### Q3: The synthesis's required-lane statement is inaccurate and the sprint-review output contract is incomplete

- Severity: blocker.
- Affected quality dimensions: template compliance, lane coverage, and
  unsupported claims.
- Evidence: `SPRINT_REVIEW.md:468-482` lists code, security, tests,
  docs/lifecycle, architecture, dependency, gap analysis, issue coverage, and
  validation, then states that no required lane was missing or skipped. The
  sprint-review contract also requires explicit `evidence_and_closeout`,
  `synthesis`, and `review_quality` lane entries with `run`, `skipped`, or
  `blocked` status and artifact paths or reasons. The current matrix omits all
  three. It also omits the supplemental direct contract lane even though P1-19
  and P2-11 identify that artifact as their source, and the metadata's
  specialist list at `SPRINT_REVIEW.md:625-627` does not name it. The matrix
  does not record optional `release_evidence` or publication redaction review
  as skipped or not applicable. The scope section does not explicitly state the
  review scope type, umbrella issue, complete PR list, changed surfaces, or
  skipped surfaces.
- Required correction before publication: replace the matrix with the complete
  sprint-review lane vocabulary and status model. Map `evidence_and_closeout`
  to the artifacts that actually perform it, map `synthesis` to
  `SPRINT_REVIEW.md`, map `review_quality` to this artifact after its blockers
  are resolved, and record every optional lane as run, skipped, blocked, or not
  applicable with a reason. Complete the scope summary fields required by the
  sprint-review output contract. Remove the "No required specialist lane was
  missing or skipped" sentence unless the corrected matrix proves it.

### Q4: Publication intent and redaction status are undeclared

- Severity: blocker.
- Affected quality dimensions: publication safety, evidence boundary, and
  template compliance.
- Evidence: `DESIGN.md:41-44` and `SPRINT_REVIEW.md:607-617` define non-claims
  but do not identify the intended audience or classify publication as internal,
  customer-private, or public. No redaction-and-evidence audit or explicit
  redaction status appears in the packet. The review includes security claims,
  token-path policy, live GitHub observations, timestamps, and descriptions of
  machine-local lifecycle evidence, so publication safety cannot be inferred
  from the non-claims section alone.
- Required correction before publication: declare the publication intent and
  audience. For customer-private or public publication, run a bounded
  redaction-and-evidence audit and retain its status, reviewed surfaces,
  corrections, and residual risks. For internal-only use, state that boundary
  explicitly and identify which evidence must be re-audited before any wider
  distribution. Do not mark this packet publication-ready from this evaluation.

## Warnings

### W1: Two dedupe decisions remain incomplete

- `P1-12` is primarily the missing executable proof for the concrete GitHub
  boundary defects in `P1-02` and `P1-03`, but
  `SPRINT_REVIEW.md:535-557` does not explain why it remains a separate finding
  rather than a validation gap attached to those findings.
- `P1-14` and `P2-08` both report current operator guidance that contradicts
  final selector authority. The dedupe notes explain the grouping inside
  P1-14, but not the remaining boundary between P1-14 and P2-08.
- `P1-06` reports unsafe recovery implementation paths while `P1-19` reports
  that heartbeat and recovery have no authorized operator route. These are
  plausibly distinct implementation-safety and route-completeness defects, but
  `SPRINT_REVIEW.md:535-557` discusses P1-06 without explaining why P1-19 is
  retained separately.
- Required correction: either merge P1-12 into the validation gaps for
  P1-02/P1-03 and merge the overlapping authority-doc findings, or add explicit
  mechanism, impact, owner, and non-overlap rationale for each retained
  finding. Add the same explicit non-overlap rationale for P1-06/P1-19.

### W2: P1-12 is not calibrated to the packet's own severity policy

- `SPRINT_REVIEW.md:5-11` reserves P1 for a high-impact failure that invalidates
  canonical truth or blocks the supported workflow. P1-12 demonstrates absent
  test realism and possible undetected regressions, not a separately triggered
  production failure. The concrete remote-identity and caller-policy failures
  are already P1-02 and P1-03.
- Required correction: classify the missing GitHub-boundary proof as a P2
  validation/control gap or as missing proof under P1-02/P1-03. Retain P1 only
  if the synthesis identifies a sprint acceptance requirement that the absent
  executable proof directly violates and explains why that violation itself
  meets the P1 impact threshold.

### W3: Follow-up routing is not traceable per finding

- All synthesized findings include impact and evidence, and the grouped routing
  in `SPRINT_REVIEW.md:574-605` is useful. However, the findings do not each
  carry a recommended correction and validation gap, and the eleven routing
  entries do not map explicitly to all 30 finding IDs.
- Required correction: add a compact mapping from every finding ID to owner,
  required correction, proving validation, and disposition (`must fix before
  acceptance`, `follow-on`, or `packet-only pending operator judgment`). This
  is routing only and must not create issues or imply remediation approval.

### W4: Live issue and PR observations need durable source pointers

- `ISSUE_COVERAGE.md` clearly records dates, issue numbers, PR numbers, merge
  commits, and dispositions, but the packet does not retain query output,
  immutable API references, or direct source links for the live observations.
- Required correction: add repo-relative captured metadata or stable GitHub
  issue/PR/commit links with observation timestamps. Preserve the existing
  caveat that live metadata can change.

## Quality Gate Summary

- Status: `fail`.
- Mode: `pre_publication_gate` over the complete issue #5375 packet.
- Publication intent: unspecified by the source packet.
- Score: 60/100. The score is diagnostic; any blocker is independently
  sufficient to prevent publication.
- Decision: the packet is useful for internal review and contains substantial
  source-grounded work, but it is not publication-ready until Q1-Q4 are
  corrected and this gate is rerun.

## Scope And Source

- Packet root: `docs/milestones/v0.91.7/review/csdlc-v2/issue-5375/`.
- Primary synthesis: `SPRINT_REVIEW.md`.
- Supporting artifacts reviewed: `DESIGN.md`, `GAP_ANALYSIS.md`,
  `ISSUE_COVERAGE.md`, `VALIDATION.md`, `REVIEW_FLOW.mmd`, and
  `REVIEW_FLOW.svg`.
- Specialist artifacts reviewed: code, architecture, security, dependency,
  tests, docs/lifecycle, and direct contract review under `specialists/`.
- Reviewed packet revision: `7c3e1e0e86a4ca982231ce91c39073530c5408e6`.
- Evaluation boundary: findings-only quality assessment; no implementation,
  tests, configs, cards, existing review artifacts, or GitHub state were
  modified.

## Scorecard

| Dimension | Score | Evaluation |
| --- | ---: | --- |
| Evidence quality | 6/10 | Source references are generally precise; central local-card and live-state evidence is not durably retained. |
| Duplicate control | 6/10 | Major cross-specialist duplicates are merged, but two material overlaps remain unresolved. |
| Severity calibration | 5/10 | Most impact-based P1/P2 choices are plausible; P1-12 is a proof gap calibrated as a failure. |
| Actionability | 6/10 | Grouped owner routing exists, but no complete finding-to-correction-to-validation map exists. |
| Unsupported-claim control | 5/10 | Non-claims are strong; complete scope and required-lane claims exceed retained proof. |
| Lane and scope coverage | 5/10 | Broad review work is visible, but required lane statuses and a retained scope manifest are missing. |
| Testing-discovery separation | 10/10 | #5364-#5373 are explicitly separated, classified, and labeled when independently corroborative. |
| Sprint-review template compliance | 6/10 | Core narrative sections exist; required scope and lane fields are incomplete. |
| Residual-risk clarity | 9/10 | Non-executed destructive, GitHub, MSRV, historical replay, and external-feed boundaries are explicit. |
| Publication safety | 2/10 | Publication boundary language exists, but audience and redaction status are absent. |

## Specialist Coverage

- Present in the packet: code, tests, docs/lifecycle, security, architecture,
  dependency, gap analysis, issue/PR coverage, validation, synthesis, and a
  direct operator contract check. The direct contract check supports P1-19 and
  P2-11 but is not represented in the synthesis coverage matrix or metadata.
- Strongest coverage: source-level behavioral tracing, negative-proof discovery,
  Gate 10 authority analysis, lifecycle/closeout comparison, and dependency/MSRV
  inspection.
- Coverage not proven by the packet: a retained changed-path/evidence manifest,
  publication redaction review, and the full sprint-review lane-status matrix.
- No specialist finding was rejected solely because its lane did not execute a
  destructive, credential-bearing, networked, or live-mutating reproduction;
  those limits are generally stated correctly.

## Template Compliance

- Present: findings first; scope/issue coverage; specialist matrix; testing
  discovery boundary; lifecycle and closeout truth; validation adequacy; dedupe
  notes; residual risk; follow-up routing; and non-claims.
- Incomplete: explicit scope type, controlling umbrella, complete PR list in the
  synthesis, changed surfaces, skipped surfaces, required lane statuses and
  artifact paths, and review-quality status.
- Missing for publication: declared audience/publication intent and redaction
  status.

## Unsupported Claims Check

- Unsupported as written: "No required specialist lane was missing or skipped"
  in `SPRINT_REVIEW.md:482`.
- Insufficiently retained: complete 108-card inventory and contradiction claims
  used by P1-15.
- Insufficiently demonstrated: complete/all/every surface coverage without a
  retained scope manifest.
- Properly bounded: no merge approval, release approval, remediation-complete,
  exploit-success, vulnerability-free, legal-approval, or all-acceptance-passed
  claim is made.

## Residual Risk Clarity

Residual risk is one of the packet's strongest areas. `SPRINT_REVIEW.md:559-572`
and the specialist artifacts distinguish passing expected-path checks from
unexecuted GitHub, filesystem, process-isolation, concurrency, MSRV, external
database, and historical cutover proofs. Before publication, the packet must
also state that unretained local-card evidence and mutable live metadata limit
independent reconstruction.

## Publication Boundary

This evaluation does not approve publication, sprint closure, remediation,
merge, release, or finding disposition. Status remains `fail`. Publication must
wait for Q1-Q4, correction of the warning-level quality defects, and a fresh
quality evaluation over the revised packet.

## Recommended Handoffs

- `repo-review-synthesis`: resolve duplicate boundaries, severity calibration,
  per-finding correction/validation mapping, and synthesis template fields.
- `sprint-review`: reconcile the complete scope and lane matrix against the
  retained evidence index.
- `redaction-and-evidence-auditor`: establish publication intent, redaction
  status, and evidence-boundary safety before any external distribution.
- Human operator: decide the publication audience and whether machine-local
  lifecycle observations may be retained in sanitized form.
